Comprehensive analysis of recent biochemical and biologic findings regarding a newly discovered protein-PELP1/MNAR

Clinical and Experimental Metastasis

Volumn 23, Issue 1, 2006, Pages 1-7

  Rajhans, Rajib ^a   Vadlamudi, Ratna K ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Coregulators; Estrogen receptor; Metastasis; PELP1 MNAR; Tumorigenesis

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; GLUTAMIC ACID; GROWTH FACTOR; LEUCINE; PROLINE; PROTEIN PELP1 MNAR; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

CANCER GROWTH; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; HORMONE RESPONSE; METASTASIS; MOLECULAR INTERACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RNA SPLICING; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; ESTRADIOL; FEMALE; HUMANS; NEOPLASM METASTASIS; ONCOGENES; RECEPTORS, ESTROGEN; RNA SPLICING; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 33750061041     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-006-9019-9     Document Type: Review

References (33)

1. Ariazi EA, Ariazi JL, Cordera F, Jordan VC (2006) Estrogen receptors as therapeutic targets in breast cancer. Curr Top Med Chem 6:195-216
2. Hall JM, McDonnell DP (2005) Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. Mol Interv 5:343-357
3. Gururaj AE, Rayala SK, Vadlamudi RK, Kumar R (2006) Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations. Clin Cancer Res 12:1001s-1007s
4. Schiff R, Massarweh SA, Shou J, Bharwani L, Arpino G, Rimawi M et al (2005) Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators. Cancer Chemother Pharmacol Suppl 1:10-20
5. Kuang SQ, Liao L, Zhang H, Lee AV, O'Malley BW, Xu J (2004) AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice. Cancer Res 64:1875-1885
6. Torres-Arzayus MI, Font de MJ, Yuan J, Vazquez F, Bronson R, Rue M et al (2004) High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 6:263-274
7. Balasenthil S, Vadlamudi RK (2003) Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein. J Biol Chem 278:22119-22127
8. Vadlamudi RK, Wang RA, Mazumdar A, Kim Y, Shin J, Sahin A et al (2001) Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha. J Biol Chem 276:38272-38279
9. Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ (2002) Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99:14783-14788
10. Khan MM, Hadman M, Wakade C, De Sevilla LM, Dhandapani KM, Mahesh VB et al (2005) Cloning, expression, and localization of MNAR/PELP1 in rodent brain: colocalization in estrogen receptor-alpha but not in gonadotropin-releasing hormone-positive neurons. Endocrinology 146:5215-5227
11. Pawlak J, Beyer C (2005) Developmental expression of MNAR mRNA in the mouse brain. Cell Tissue Res 320:545-549
12. Greger JG, Guo Y, Henderson R, Ross JF, Cheskis BJ (2006) Characterization of MNAR expression. Steroids 71:317-322
13. Mishra SK, Balasenthil S, Nguyen D, Vadlamudi RK (2004) Cloning and functional characterization of PELP1/MNAR promoter. Gene 330:115-122
14. Nagpal J, Nair S, Pothana S, Tekmal R, Kumar R, Vadlamudi RK (2006) Growth factor regulation of PELP1/MNAR functions: role of PKA-dependent phosphorylation. Proc Amer Cancer Res 47:2933
15. Ballif BA, Villen J, Beausoleil SA, Schwartz D, Gygi SP (2004) Phosphoproteomic analysis of the developing mouse brain. Mol Cell Proteom 3:1093-1101
16. Manavathi B, Nair SS, Wang RA, Kumar R, Vadlamudi RK (2005) Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation. Cancer Res 65:5571-5577
17. Vadlamudi RK, Balasenthil S, Broaddus RR, Gustafsson JA, Kumar R (2004) Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors. J Clin Endocrinol Metab 89:6130-6138
18. Haas D, White SN, Lutz LB, Rasar M, Hammes SR (2005) The modulator of nongenomic actions of the estrogen receptor (MNAR) regulates transcription-independent androgen receptor-mediated signaling: evidence that MNAR participates in G protein-regulated meiosis in Xenopus laevis oocytes. Mol Endocrinol 19:2035-2046
19. Choi YB, Ko JK, Shin J (2004) The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains. J Biol Chem 279:50930-50941
20. Nair SS, Mishra SK, Yang Z, Balasenthil S, Kumar R, Vadlamudi RK (2004) Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells. Cancer Res 64:6416-6423
21. Mishra SK, Mazumdar A, Vadlamudi RK, Li F, Wang RA, Yu W et al (2003) MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions. J Biol Chem 278:19209-19219
22. Barletta F, Wong CW, McNally C, Komm BS, Katzenellenbogen B, Cheskis BJ (2004) Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc. Mol Endocrinol 18:1096-1108
23. Vadlamudi RK, Manavathi B, Balasenthil S, Nair SS, Yang Z, Sahin AA et al (2005) Functional implications of altered subcellular localization of PELP1 in breast cancer cells. Cancer Res 65:7724-7732
24. Nair S, Rajhans R, Nagpal J, Guider J, Kumar R, Vadlamudi RK (2006) PELP1/MNAR interacts with BCAS2: potential role in ER-mediated splicing. Proc Amer Cancer Res 47:2930
25. Rayala SK, Hollander P, Balasenthil S, Molli PR, Bean AJ, Vadlamudi RK et al (2006) Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) interacts with PELP1 and activates MAPK. J Biol Chem 281:4395-4403
26. Nair S, Seetharaman B, Mueller JMKS, Schule R, Kumar R, Vadlamudi RK (2006) PELp1/MNAR modulates LIM-only coactivator FHL2 transactivation functions. Proc Amer Cancer Res 46:1279
27. Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA et al (2004) Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Cancer Res 64:7156-7168
28. Singh R, Gururaj AE, Vadlamudi RK, Kumar R (2006) 9-cis-retinoic acid upregulates expression of transcriptional coregulator PELP1, a novel coactivator of RXR. J Biol Chem 10.1074/jbc.M601593200
29. Rajhans R, Nair S, Tekmal R, Kumar R, Vadlamudi RK (2006) Cellular transformation and oncogenesis by PELP1/NMAR, a major broad coactivator in mammalian cells. Proc Amer Cancer Res 47:4215
30. Heppner GH, Miller FR, Shekhar PM (2000) Nontransgenic models of breast cancer. Breast Cancer Res 2:331-334
31. Mishra SK, Talukder AH, Gururaj AE, Yang Z, Singh RR, Mahoney MG et al (2004) Upstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway. J Biol Chem 279:32709-32715
32. Rayala SK, Mascarenhas J, Vadlamudi RK, Kumar R (2006) Altered localization of a coactivator sensitizes breast cancer cells to tumor necrosis factor-induced apoptosis. Mol Cancer Ther 5:230-237
33. Vadlamudi RK, Balasenthil S, Sahin AA, Kies M, Weber RS, Kumar R et al (2005) Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets. Hum Pathol 36:670-675